Department of Surgery, Division of Transplantation, University of Minnesota, Minneapolis, MN 55455, USA; Asan-Minnesota Institute for Innovating Transplantation, University of Minnesota, Minneapolis, MN 55455, USA; Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Department of Liver Transplantation and Hepatobiliary Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea; Asan-Minnesota Institute for Innovating Transplantation, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea.
Tissue Cell. 2020 Feb;62:101310. doi: 10.1016/j.tice.2019.101310. Epub 2019 Oct 21.
The study of the liver microenvironment and hepatocyte's response to this environment in the setting of healthy liver, cirrhotic liver or cultured primary human hepatocytes (PHHs) addresses key questions for the development of novel liver therapies and predicts relevance of ex vivo PHHs models in liver biology. This study compared quantitative gene and protein expression of the inflammatory profile, oxidative stress response, angiogenesis and homing mechanisms in the biopsies of healthy and cirrhotic human livers and isolated PHHs. These profiles were correlated with the metabolic health of liver and PHHs defined by albumin production. The analysis demonstrated that cirrhotic liver and PHHs exhibited a distinct upregulation of the pro-inflammatory, oxidative stress and homing mechanism markers when compared to normal liver. The upregulation of the oxidative stress markers in PHHs inversely correlated with the albumin production. PHHs had diverse secretion of matrix metalloproteinases and their inhibitors, reflective of the cellular response to non-physiological culture conditions. The current study suggests that ex vivo PHHs manifest adaptive behavior by upregulating stress mechanisms (similar to the cirrhotic liver), downregulating normal metabolic function and upregulating matrix turnover. The ex vivo profile of PHHs may limit their therapeutic functionality and metabolic capacity to serve as in vitro metabolism and toxicology models.
研究健康肝脏、肝硬化肝脏或培养的原代人肝细胞 (PHH) 的肝微环境和肝细胞对这种环境的反应,解决了开发新型肝脏治疗方法的关键问题,并预测了体外 PHH 模型在肝脏生物学中的相关性。本研究比较了健康和肝硬化人类肝脏活检组织以及分离的 PHH 中炎症特征、氧化应激反应、血管生成和归巢机制的定量基因和蛋白表达。这些特征与肝脏和 PHH 的代谢健康相关,由白蛋白产生定义。分析表明,与正常肝脏相比,肝硬化肝脏和 PHH 表现出明显的促炎、氧化应激和归巢机制标志物上调。PHH 中氧化应激标志物的上调与白蛋白产生呈负相关。PHH 基质金属蛋白酶及其抑制剂的分泌具有多样性,反映了细胞对非生理培养条件的反应。本研究表明,体外 PHH 通过上调应激机制(类似于肝硬化肝脏)、下调正常代谢功能和上调基质周转来表现出适应性行为。PHH 的体外特征可能限制了它们作为体外代谢和毒理学模型的治疗功能和代谢能力。